1. Home
  2. QDEL vs INMD Comparison

QDEL vs INMD Comparison

Compare QDEL & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuidelOrtho Corporation

QDEL

QuidelOrtho Corporation

HOLD

Current Price

$14.12

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo InMode Ltd.

INMD

InMode Ltd.

HOLD

Current Price

$13.49

Market Cap

842.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QDEL
INMD
Founded
1979
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
842.0M
IPO Year
2022
2018

Fundamental Metrics

Financial Performance
Metric
QDEL
INMD
Price
$14.12
$13.49
Analyst Decision
Hold
Hold
Analyst Count
4
5
Target Price
$28.25
$17.33
AVG Volume (30 Days)
1.7M
689.4K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
45.35
N/A
EPS
N/A
N/A
Revenue
$2,730,200,000.00
N/A
Revenue This Year
$3.51
$1.74
Revenue Next Year
$3.86
$3.26
P/E Ratio
N/A
$10.11
Revenue Growth
N/A
N/A
52 Week Low
$9.92
$12.72
52 Week High
$35.58
$16.74

Technical Indicators

Market Signals
Indicator
QDEL
INMD
Relative Strength Index (RSI) 57.86 41.90
Support Level $10.39 $13.29
Resistance Level $15.76 $13.87
Average True Range (ATR) 1.05 0.22
MACD 0.15 -0.01
Stochastic Oscillator 62.77 17.67

Price Performance

Historical Comparison
QDEL
INMD

About QDEL QuidelOrtho Corporation

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

Share on Social Networks: